Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | +5.30% | +4.61% | -43.82% |
May. 10 | Accuray Incorporated Announces Executive Changes, Effective May 17, 2024 | CI |
May. 01 | Earnings Flash (ARAY) ACCURAY INCORPORATED Posts Q3 Revenue $101.1M, vs. Street Est of $113.6M | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-43.82% | 158M | C | ||
+7.87% | 219B | B | ||
+11.83% | 192B | B- | ||
+18.87% | 142B | B- | ||
+30.03% | 111B | A- | ||
+1.33% | 65.32B | A- | ||
+14.15% | 52.45B | B+ | ||
+2.68% | 49.8B | B+ | ||
+6.60% | 43.43B | A | ||
+1.85% | 35.95B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ARAY Stock
- Ratings Accuray Incorporated